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Abstract
Background: Several computational methods exist to suggest rational genetic interventions that improve the
productivity of industrial strains. Nonetheless, these methods are less effective to predict possible genetic responses
of the strain after the intervention. This problem requires a better understanding of potential alternative metabolic
and regulatory pathways able to counteract the targeted intervention.
Results: Here we present SPABBATS, an algorithm based on Boolean satisfiability (SAT) that computes alternative
metabolic pathways between input and output species in a reconstructed network. The pathways can be
constructed iteratively in order of increasing complexity. SPABBATS allows the accumulation of intermediates in the
pathways, which permits discovering pathways missed by most traditional pathway analysis methods. In addition,
we provide a proof of concept experiment for the validity of the algorithm. We deleted the genes for the
glutamate dehydrogenases of the Gram-positive bacterium Bacillus subtilis and isolated suppressor mutant strains
able to grow on glutamate as single carbon source. Our SAT approach proposed candidate alternative pathways
which were decisive to pinpoint the exact mutation of the suppressor strain.
Conclusions: SPABBATS is the first application of SAT techniques to metabolic problems. It is particularly useful for
the characterization of metabolic suppressor mutants and can be used in a synthetic biology setting to design
new pathways with specific input-output requirements.
Background
A holistic understanding of cellular metabolism is cen-
tral to systems biology and metabolic engineering: In
order to amplify the flux through production pathways
in industrial strains we have to understand how the
metabolic network responds to our interventions.
Several methods can suggest rational interventions
that may lead to favourable industrial phenotypes (see
[1] for a review). Their goal is to optimize the distribu-
tion of metabolic fluxes towards the product of interest,
either directly (e.g. FBA, MOMA or ROOM) or indir-
ectly by coupling it to another characteristic (e.g. Opt-
Knock) that facilitates further strain improvements via
mutation and screening.
While these methods can predict a final flux distribu-
tion, they do not predict the range of genetic and meta-
bolic responses of the organism after the targeted
mutation. At the same time, it would be highly desirable
to have tools that may predict these responses, since
they can suggest ways to generate more stable strains,
or accelerate the adaptation to an intended optimal flux.
The challenge of the question is the need to understand
why particular genetic responses make sense in an evo-
lutionary setting. Thus, the ultimate question is: Which
parallel pathways - that were not active previously -
result in an adaptive advantage under the screening
conditions?
Pathway analysis has received increased attention due
to the reconstruction of genome scale metabolic net-
works for many organisms. These methods can be
divided into two categories: stoichiometric and path
oriented (see [2] for a review). The first approach gener-
ates all pathways that conform to the pseudo-steady-state
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any medium, provided the original work is properly cited.assumption for internal metabolites. However, it presents
two problems: the number of predicted pathways is in
the order of millions for genome scale models, making
the approach totally intractable for the question at hand
[3]. Its second shortcoming is the constraint imposed by
the pseudo-steady-state assumption for internal metabo-
lites. This assumption may rule out feasible pathways or
(in case we include a large number of “freely available”
metabolites) result again in a combinatorial explosion of
pathways. The alternative approach - path oriented path-
way reconstructions - is advantageous since it usually
generates a small (and thus tractable) set of possible
pathways. This is due to the choice of starting and ending
metabolites and heuristics on the characteristics of the
“optimal” pathway. However, the path-oriented approach
may result in unrealistic pathways that consume internal
metabolites not present in sufficient quantities inside the
cell.
What is needed is an algorithm that reconstructs stoi-
chiometrically balanced pathways in increasing order of
complexity, with relaxed mass-balance constraints in
comparison to the traditional pseudo-steady-state
restriction.
A solution based on mixed-integer linear program-
ming (MILP) has been suggested by de Figueiredo et al.
[4], but it has not been used in an evolutionary context
so far. Here we describe the use of Boolean satisfiability
(SAT, [5]) for the reconstruction of alternative pathways
in metabolic networks. Given a set of basal metabolites
(that are considered freely available) and a set of target
metabolites (whose concentration must increase), our
SAT method constructs the shortest pathway between
the basal and target sets (SPABBATS) of metabolites
that is stoichiometrically balanced, while allowing the
concentration of the intermediate metabolites to
increase, if needed. The constraints are more relaxed
than the ones for e.g. flux balance analysis, thus retain-
ing the metabolically significant pathways. Using the
algorithm iteratively, we obtain a prioritized list of path-
ways, whose elements can be tested individually by com-
mon molecular biology techniques.
To demonstrate the power of this concept, we applied
the SPABBATS algorithm to a complex physiological
problem, which is a result of an evolutionary experi-
ment. We have elucidated a novel pathway of glutamate
degradation present in the metabolic network of B. sub-
tilis that had been decryptified upon inactivation of the
normal glutamate catabolic genes. By using our SAT
approach, we proposed four different new pathways that
could be present in the mutant to utilize glutamate as
single carbon source. These predictions were experi-
mentally tested and revealed that one of these pathways
was indeed active in the mutant strain and that this
novel “suppressor” pathway is required and sufficient for
glutamate utilization. This proves that the results of our
approach correspond to valid metabolic alternatives for
living cells.
Results
Isolation of a mutation that allows a bypass of the
glutamate dehydrogenase for the utilization of glutamate
Glutamate is the most abundant metabolite in a bacter-
ial cell. Although its exact concentration in B. subtilis is
unknown, it is known to account for about 40% of the
internal metabolite pool of an Escherichia coli cell [6].
Glutamate serves as an osmotic regulator [7], as well as
universal amino group donor in anabolism thus linking
carbon and nitrogen metabolism [8]. In B. subtilis,a t
least 37 reactions make use of glutamate as cofactor for
transamination [9].
The key reactions of glutamate biosynthesis and
degradation in B. subtilis a r es u m m a r i z e di nF i g u r e1 .
2-oxoglutarate, an intermediate of the citric acid cycle,
is aminated by the glutamate synthase, encoded by the
gltA and gltB genes. Glutamate degradation to 2-oxo-
glutarate requires the glutamate dehydrogenase RocG.
Additionally, the laboratory strain B. subtilis 168 har-
bours a cryptic gene, gudB, coding for an inactive glu-
tamate dehydrogenase. This gene is readily decryptified
in rocG mutants [10,11]. In addition, RocG controls
the expression of the gltAB operon and therefore pre-
vents glutamate biosynthesis in the presence of argi-
nine [12,13].
Inactivation of both the rocG and the gudB gene
results in loss of any glutamate dehydrogenase activity
and concomitant inability of the bacteria to utilize gluta-
mate [10,11]. The rocG gudB double mutant strain GP28
grows poorly on SP medium (an amino acid-rich
Figure 1 Key reactions for glutamate biosynthesis and
degradation in Bacillus subtilis. Glutamate is the universal amino
group donor in all living cells and in that way links the carbon and
nitrogen metabolisms. In B. subtilis the synthesis of glutamate
depends on the glutamate synthase GltAB. In addition, the genome
encodes two glutamate dehydrogenases, RocG and GudB, although
the latter is inactive in the laboratory B. subtilis strain 168 (see text).
The synthesis and degradation of glutamate are tightly regulated in
response to the availability of carbon and nitrogen sources.
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ducts of arginine metabolism [14]. However, cultivation
of GP28 on SP plates eventually resulted in the isolation
of a mutant (GP717) that carries a mutation inactivating
the gltB gene, encoding a subunit of the glutamate
synthase [11]. This mutation leads to glutamate auxotro-
phy and might therefore prevent the accumulation of
intermediates of arginine degradation. We have observed
that toxic intermediates of arginine degradation result in
poor growth of mutants lacking a functional glutamate
dehydrogenase (our unpublished results). If intrinsic glu-
tamate synthesis is blocked by a mutation, such an accu-
mulation of toxic intermediates might be reduced. A
careful analysis of the mutant strain revealed that it had
acquired the ability to utilize glutamate as the only
source of carbon and energy. This might have resulted
from a re-activation of the rocG or gudB genes or from
the establishment of a novel pathway for glutamate utili-
zation. We tested therefore the rocG and gudB alleles by
PCR analysis. Both the transposon insertion in rocG and
the replacement of the gudB gene by a chloramphenicol
resistance gene were identical to the parent strain GP28.
Clearly, a new pathway of glutamate degradation was
activated in this suppressor mutant that was not active
in the wild type and rocG gudB mutant cells.
Development of a pathway-finding algorithm
The most reasonable hypothesis to explain the suppres-
sion was that the mutation had activated a redundant
pathway that is inactive in the wild type strain in a med-
ium with glutamate as single carbon source. Since gluta-
mate is a highly abundant metabolite and is involved as
a substrate in 20 reactions in B. subtilis,i tw a sn o t
obvious which mutation could have lead to glutamate
utilization proficiency in B. subtilis GP717.
To address this problem by use of the power of bioin-
formatics, we developed an approach that harnesses the
strengths of Boolean satisfiability (SAT) to find valid
pathways (see Materials and Methods). It is able to find
short pathways between a basis and a target set (SPAB-
BATS) of metabolites that can operate in a sustained
way. It is convenient for its focus on short pathways and
the fact that it can calculate pathways that comply with
the steady-state constraint. It also allows the relaxation
of this constraint, by allowing some metabolites to accu-
mulate if necessary.
The first four pathways suggested by our algorithm
are presented in Figure 2. In each case, the first step is a
transamination reaction that leads to the production of
2-oxoglutarate. The substrate for transamination is then
replenished via the remaining reaction(s) of the pathway.
The first pathway (Figure 2A) involves transamination to
form alanine and subsequent oxidative deamination of
alanine by the alanine dehydrogenase Ald resulting in
the net formation of 2-oxoglutarate. The next two path-
w a y s( F i g u r e2 B )a r ev e r ys i m i l a ra n di n v o l v ee n z y m e s
of branched amino acid metabolism. In the transamina-
tion step, both pathways use the transaminases YbgE
and YwaA. The branched chain amino acid dehydrogen-
ase Bcd is then used for the oxidative deamination of
the transamination products valine or leucine. Again,
the net result of this pathway is the production of
Figure 2 Predictions of alternative pathways for glutamate
utilization based on SAT techniques.AB. subtilis strain (GP28)
was constructed that lacks the glutamate dehydrogenases. An
evolutionary adaptation resulted in a strain (GP717) that acquired
the capacity to grow on glutamate as single carbon source. Using a
SAT based search algorithm (see Materials and Methods) we
predicted four alternative pathways that could be activate in the
GP717. The genes coding for the enzymes in orange were analyzed
further (see text). 4-m-2-o-p-ate = 4-methyl-2-oxo-pentanoate; 3-m-
2-o-b-ate = 3-methyl-2-oxo-butanoate.
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(Figure 2C) requires four steps, (i) the reaction of the
aspartate aminotransferase AspB, (ii) the deamination of
asparate to fumarate by the aspartase AnsB, (iii) the
fumarase reaction (CitG) of the citric acid cycle, and
finally (iv) the oxidation of malate by the malate dehy-
drogenase Mdh. As described for the other pathways,
this reaction sequence results in the net formation of
2-oxoglutarate from glutamate. Since the original
mutant GP28 did not grow with glutamate as the single
carbon source, it is obviously not able to use any of
these proposed pathways suggesting that they were acti-
vated by a suppressor mutation in GP717.
Experimental validation of the predictions
Our experiments were performed in minimal medium
suggesting that the activity of transaminases was not lim-
iting. Similarly, the two enzymes of the citric acid cycle
(CitG and Mdh) are constitutively expressed [15-17].
Thus, the mutation may have affected the expression of
one of the deaminases Ald, Bcd or AnsB. This hypothesis
was tested by reverse transcription-real-time quantitative
PCR. As shown in Figure 3, the levels of ald and bcd
mRNA are comparable for the original mutant GP28 and
the suppressor strain GP717. In contrast, a strong
increase of the expression of the ansAB operon encoding
the asparaginase and aspartase was observed for the sup-
pressor mutant that was able to utilize glutamate. This
observation suggests that it is the high-level expression of
AnsB that allows glutamate utilization in GP717.
T h ei n v o l v e m e n to ft h ea s p a r t a s eA n s Bi nt h en o v e l
glutamate utilization pathway was verified by analysing
the effect of a deletion of the ansAB operon. Growth of
the original strain GP28, the suppressor mutant GP717
and its isogenic ΔansAB mutant derivative GP1154 in
minimal medium with glutamate or with glutamate and
glucose was recorded. As shown in Figure 4, all three
strains were able to grow with glutamate and glucose. In
contrast, the deletion of the ansAB operon reverted the
capability of the suppressor strain of using glutamate as
the single carbon source, and the ΔansAB mutant
GP1154 was unable to grow with glutamate as was the
original strain GP28. This finding strongly supports the
idea that the activity of the aspartase AnsB is the reason
for the ability of the suppressor strain GP717 to utilize
glutamate.
The ansAB operon is induced in the presence of
asparagine due to inactivation of the AnsR repressor
[18-20]. A comparative analysis of ansAB expression
revealed about 30-fold induction by asparagine in GP28,
whereas the expression levels were unaffected by the
availability of asparagine in the suppressor mutant
GP717 (data not shown). The observed induction in the
wild type strain is good agreement with previous
reports. The loss of regulation in GP717 and the high
expression of the operon as compared to GP28 suggest
constitutive ansAB expression that might be the result
of an inactivation of the ansR repressor gene.
To test the hypothesis that inactivation of the AnsR
repressor allowed glutamate utilization by GP717, we
performed two tests: First, we deleted the ansR gene of
the parental strain GP28 and tested the ability of the
resulting strain GP811 to grow with glutamate as the sin-
gle carbon source. Unlike GP28, this strain GP811
(ΔansR) grew in CE minimal medium. Thus, inactivation
of the ansR gene is sufficient to open a new pathway for
glutamate catabolism. In a complementary approach, we
complemented B. subtilis GP717 with a plasmid-borne
copy of the ansR gene (present on pGP873) and tested
the ability of the transformants to use glutamate. While
the control strain (GP717 transformed with the empty
vector pBQ200) grew well on CE medium, expression of
AnsR from the plasmid completely blocked growth in
this medium, i. e. the utilization of glutamate. This result
confirms that a mutation in the ansR gene must be pre-
sent in GP717 and that it is this mutation, which confers
t h eb a c t e r i aw i t ht h ea b i l i t yt ou t i l i z eg l u t a m a t ev i at h e
new aspartase pathway.
To identify the mutation in ansR,w es e q u e n c e dt h e
ansR alleles of the parental strain GP28 and the gluta-
mate-utilizing suppressor mutant GP717. While the wild
type allele of ansR was present in GP28, a C-to-A sub-
stitution at position 107 of the ansR open reading frame
was found in GP717. This mutation changes codon 36
from UCA (Ser) to UAA (stop) and results in premature
translation termination and the formation of an incom-
plete and non-functional AnsR repressor protein.
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Figure 3 Comparison of gene expression patterns between
mutant and parental strains, based on the predictions of the
SPABBATS algorithm for pathway analysis. The predictions of
the SPABBATS algorithm (see Figure 2) were further characterised by
transcription analysis. The expression of the ald and bcd genes
remains constant between the mutant (GP717) and parental (GP28)
strains, suggesting that these genes are not involved in the newly
activated catabolic pathway. In contrast, the expression of the ansAB
operon is strongly increased in the mutant. This hints to a gain of
function in the mutant strain that was analyzed further.
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metabolic pathway predicted by the SPABBATS algo-
rithm corresponds to a valid metabolic state of the rocG
gudB ansR mutant strain GP717.
Discussion
Comparison of SPABBATS with other methods for
metabolic analysis
Flux balance analysis [21] and the majority of methods
derived from it are based on constraining the admissible
intracellular flux space to steady-state and choosing an
adequate optimality criterion to calculate intracellular
fluxes. Commonly used optimization criteria are bio-
mass production and the maximization of energy
output.
Although these methods predict the essentiality of
genes with high accuracy [9], they are less suited for the
characterization of alternative metabolic pathways in
viable mutants. On the one hand, by restricting the
admissible intracellular flux to steady-state, they discard
pathways where a by-product accumulates. Nonetheless,
the cell is still viable if this by-product is consumed by
other pathways in the cell, not directly related to the
process that is studied. SPABBATS solves this problem
by allowing a larger flux-space, where intermediate pro-
ducts can accumulate, if necessary.
On the other hand, the optimality criterion can be
artificial. For instance, maximizing cellular growth might
lead to a theoretical maximum growth rate, or a flux
distribution that is as close to the wild-type flux as pos-
sible, but it is hard to argue that the regulatory network
of the strain is directed to the same target. The path-
ways discovered by SPABBATS are a structural property
of the network and do not depend on an extrinsic
optimality criterion (beyond the number of reactions of
the resulting pathway). For this reason, the resulting
pathways can be interpreted objectively.
Other methods for structural decomposition (e.g.
extreme pathways and elementary flux modes, see [2] for
a review) rely on the same steady-state restriction of FBA
related methods and for this reason share some of their
disadvantages. Moreover, SPABBATS does not require
the calculation of all possible pathways. Instead, it can be
used iteratively to calculate pathways of increasing
length, which results in a dramatic improvement in per-
formance for finding relevant pathways in large networks.
An advantage over the method of de Figueiredo et al.
[4] is that we do not make use of an optimization fra-
mework, but select for satisfiability instead. Similar pro-
blems in other areas of computational biology (e.g. [22])
show a performance improvement of SAT methods over
traditional mixed-integer linear programming methods.
Future perspectives
So far, our analysis of networks using SAT has been
restricted to metabolic networks. Nonetheless, since
SAT is especially suited for problems that involve Boo-
lean constraints, it is possible to expand the analysis to
Figure 4 Requirement of the aspartase gene in the alternative pathway for glutamate utilization. The SPABBATS algorithm (see Figure 2)
and the transcription analysis (see Figure 3) suggested that the overexpression of the asparaginase and aspartase genes (ansAB) is the cause for
the metabolic gain of function of the mutant strain GP717. To prove this, the ansAB operon was deleted in the GP717 strain. The resulting strain
GP1154 lost the capacity to utilize glutamate as single carbon source. This strongly indicates that the induction of the aspartase gene is required
and sufficient for the newly activated catabolic pathway. CE = Minimal medium containing 0.5% glutamate, CE-Glc = CE medium with an
addition 0.5% glucose.
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reconstruction of the metabolic network together with
its regulatory complement. This reconstruction is in
progress [23,24].
In parallel, we envision the development of novel SAT
solvers that are optimized for the solution of metabolic
constraints. This will result in the adoption of SAT
based methods for metabolic engineering as well as for
the design of synthetic circuits that are able to perform
computations in the same way as their silicon-made
counterparts [25].
Conclusions
In this contribution we have shown the use of SAT
techniques to discover alternative pathways that connect
sets of starting and target species. In addition, we pro-
vided a proof of concept for the applicability of the algo-
rithm. We started with a complex physiological problem
in B. subtilis: the need to characterize a suppressor
mutation that allowed growth on glutamate without glu-
tamate dehydrogenases. SPABBATS predicted four
potential pathways for glutamate utilization that were
decisive to suggest target genes for experimentation.
These experiments confirmed the validity of the SPAB-
BATS’ prediction, closing the cycle between modelling
and wet lab experimentation.
SPABBATS relies on Boolean satisfiability (SAT) to
construct the metabolic pathways. SAT has been used
for the determination of haplotypes from sequenced
genotypes [22], the analysis of genome biology networks
[26], the understanding of myogenic differentiation [27],
and the characterization of steady states of regulatory
circuits [28,29]. Here we report the first application of
SAT techniques to metabolic problems.
The SPABBATS algorithm was applied here to a speci-
fic problem, the analysis of glutamate metabolism in B.
subtilis. However, the solution strategies are applicable to
a broad spectrum of metabolic problems. For instance,
SPABBATS can be particularly useful in the characteriza-
tion of suppressor mutants. Moreover, SPABBATS can
also be useful in synthetic biology. Although used here to
find pathways in a reconstruction of the metabolism of B.
subtilis, it is also possible to use a database of enzymes as
the starting model. In this way, it can be used to con-
struct synthetic pathways that satisfy specific input-out-
put and mass-balance requirements.
Methods
Algorithm for finding short pathways between a basis
and a target set of metabolites (SPABBATS)
Our approach draws inspiration from flux-balance ana-
lysis (FBA [21]) in the sense that it searches the flux
s p a c eo fam e t a b o l i cn e t w o r kf o rf l u x e st h a tc o m p l y
with a set of stoichiometric constraints. The major dif-
ference to FBA lies in the optimality criterion; in FBA
the value to optimize is the target flux. In our case we
change from optimization to satisfiability: we search for
a flux that satisfies all the constraints, including a maxi-
mum number of allowed reactions.
Another important difference, that is a consequence of
satisfiability approach, is that we use two variables for
each flux instead of one. The first variable is a positive
integer, which is a relative measure of the contribution
of that particular flux to the total pathway. The second
variable is Boolean and defines whether or not the parti-
cular flux takes part in the solution.
As in FBA, we define S as the stoichiometric matrix of
the network with n reactions and m compounds. Rever-
sible reactions are split into two unidirectional reactions.
We divide the set of compounds into three disjoint sets:
i) B is the set of basis compounds that are consid-
ered freely available, either because they are pro-
vided in the medium, or because they are “currency
metabolites”, whose concentration is buffered by the
whole system (e.g. ATP, ADP, NADH, etc.)
ii) T is the set of target compounds, the ones con-
strained to be produced in the pathways of interest
iii) I is the set containing all other compounds, that
can be intermediates of the resulting pathway
We use different constraints for each of these sets. The
compounds in the set B are left unconstrained. For each
compound in the set T, we write a constraint in the form:
sa b ij i i
i
n
= ∑ >
1
0, (1)
where sij is the stoichiometric coefficient of compound
j in reaction i, and ai and bi are the integer and Boolean
valued variables of reaction i, respectively. These con-
straints mean that in the solution pathway the overall
flux to these metabolites should be positive.
For the compounds in the set I w eu s eac o n s t r a i n t
similar to (1), with the difference that we use a “greater
than or equal to” (≥) sign. In FBA, an equality sign is
used here, to constraint the fluxes to the steady-state
space. We purposely do not constrain the pathway to
the steady-state space, since the candidate solutions to
the problem will not be the only pathway active in the
cell and the intermediates that are accumulated in our
pathway can be used by other pathways operating in
parallel in the system. We require the total flux to these
compounds to be non-negative, since the supposition is
that they are not present in sufficiently high amounts to
allow sustained growth on their consumption.
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of reversible reactions. This is done with constraints in
the form:
bb ij +< 2, (2)
where bi and bj are the Boolean variables of two reac-
tions that together characterize a reversible reaction.
These constraints mean that no two directions of a
reversible reaction can appear in the final pathway at
the same time.
Last, we add a constraint for the total length of the
solution. This constraint is:
bk i
i
n
= ∑ ≤
1
, (3)
where k is a positive integer value that determines the
maximum number of reactions that can appear in the
pathway. This constraint does not immediately find the
best solution, but it puts successively stricter upper-
bounds to the maximum number of reactions that are
allowed. Thus, it is able to find the shortest solution
after some iterations by choosing successively smaller
numbers for k.
The constraints for the compounds in T and I are not
linear, since each term in the sum is composed of two
variables instead of one. For this reason, a linear optimi-
zation strategy cannot be used directly. This limitation
is not present when we use the SAT-solver HySAT [30].
It is able to find assignments to the variables that satisfy
all the constraints in the system, even when these are
non-linear. It is also able to detect if no such assignment
exists.
If the shortest solution has been found, the best sub-
optimal solution can be found by adding an additional
constraint in the form:
bk i
iK
op
∈ ∑ < , (4)
where kop is the number of reactions in the shortest
solution and K is the set of indices for the reactions in
the shortest solution. In other words, we constrain the
sum of all the Boolean variables of the optimal solution
to be less than kop, thus leaving out the shortest solution
from the solution space. By iterating this process with
the Boolean variables of the sub-optimal pathway, we
can find solutions with successively higher number of
reactions.
The particular implementation of this algorithm for
the problem mentioned in the Results section is as fol-
lows: we used the genome-scale reconstruction of B.
subtilis [9]. We removed the biomass “reaction”;i ti s
useful for FBA, since it describes the target flux to cel-
lular growth, but is meaningless in our context. In
addition, we removed the reaction “glutamate dehydro-
genase” (R_GLUDxi) to simulate the conditions of the
strain GP717. We also scaled the non-integer stoichio-
metric coefficients of the model to integer values (and
divided by the greatest common denominator). In our
case, the set B contained the metabolites ATP, ADP,
NAD
+, NADH, FAD, FADH2,H 20, H
+,N H 4
+,a n dg l u -
tamate. These “currency metabolites” were chosen due
to their participation in most catabolic pathways in the
cell. The set T contained just 2-oxoglutarate. The
remaining compounds were assigned to the set I.W e
set the interval for the ai to [[1], 1000]. The calcula-
tions were done using an Intel Core2 Duo processor at
2.66 GHz, with 3.25 GB of RAM. The first pathway
(the one involving leucine as intermediate) was found
after 28 seconds. All other pathways took less than 8
minutes each to calculate.
Bacterial strains and growth conditions
All B. subtilis strains used in this work are derived
from the laboratory wild type strain 168. They are
listed in Table 1. E. coli DH5a [31] was used for clon-
ing experiments. B. subtilis was grown in C minimal
medium containing ammonium as basic source of
nitrogen [32]. Glutamate and/or glucose were added as
carbon source as indicated. The medium was supple-
mented with auxotrophic requirements (at 50 mg/l).
E. coli was grown in LB medium and transformants
were selected on plates containing ampicillin (100 μg/
ml). LB, SP and CSE plates were prepared by the addi-
tion of 17 g Bacto agar/l (Difco) to LB, SP or CSE
medium, respectively.
DNA manipulation and transformation
Transformation of E. coli and plasmid DNA extraction
were performed using standard procedures [31].
Table 1 B. subtilis strains used in this study
Strain Genotype Source or Reference
GP28 trpC2 ΔgudB::cat rocG::Tn10 spc amyE::(gltA-lacZ aphA3) [14]
GP717 trpC2 ΔgudB::cat rocG::Tn10 spc amyE::(gltA-lacZ aphA3) gltB1 ansR-C107A [11]
GP811 trpC2 ΔgudB::cat rocG::Tn10 spc amyE::(gltA-lacZ aphA3) ΔansR::tet see Materials and methods
GP1154 trpC2 ΔgudB::cat rocG::Tn10 spc amyE::(gltA-lacZ aphA3) gltB1 ansR-C107A ΔansAB::ermC see Materials and methods
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merases were used as recommended by the manufac-
turers. DNA fragments were purified from agarose gels
using the Nucleospin Extract kit (Macherey and Nagel,
Germany). Phusion DNA polymerase was used for the
polymerase chain reaction as recommended by the
manufacturer. All primer sequences are provided as
supplementary material (Additional File 1 Table S1).
DNA sequences were determined using the dideoxy
chain termination method [31]. All plasmid inserts
derived from PCR products were verified by DNA
sequencing. Chromosomal DNA of B. subtilis was iso-
lated as described [33].
E. coli transformants were selected on LB plates con-
taining ampicillin (100 μg/ml). B. subtilis was trans-
formed with plasmid DNA or PCR products according
to the two-step protocol described previously [33].
Transformants were selected on SP plates containing
tetracyclin (Tet 10 μg/ml), or erythromycin plus linco-
mycin (Em 2 μg/ml and Lin 25 μg/ml).
Plasmid and mutant strain construction
To express a plasmid-borne ansR gene in B. subtilis,w e
constructed plasmid pGP873. For this purpose the ansR
gene was amplified with the primers KG18 and KG19
using chromosomal DNA of B. subtilis as a template.
The PCR product was digested with BamHI and SalI
and cloned into the overexpression vector pBQ200 [34].
Deletion of the ansAB and ansR genes was achieved
by transformation with PCR products constructed
using oligonucleotides to amplify DNA fragments
flanking the target genes and an intervening erythro-
mycin and tetracyclin resistance cassettes from plas-
mids pDG647 and pDG1514, respectively, [35] as
described previously [36]. The PCR products were
used to transform GP717 and GP28 for the deletion of
the ansAB and ansR, respectively.
Reverse transcription-real-time quantitative PCR
For RNA isolation, the cells were grown to an OD600 of
0.5 - 0.8 and harvested. Preparation of total RNA was
carried out as described previously [37]. cDNAs were
synthesized using the One-Step RT-PCR kit (BioRad) as
described [38]. Real time quantitative PCR was carried
out on the iCycler instrument( B i o R a d )f o l l o w i n gt h e
manufacturer’s recommended protocol by using the pri-
mers KG26/KG27 for the ansA gene, KG38/KG39 for
the ald gene and KG40/KG41 for the bcd gene, respec-
tively. Their recommended data analysis procedure was
also used. The rpsE and rpsJ genes encoding constitu-
tively expressed ribosomal proteins were used as internal
controls and were amplified with the primers rpsE-RT-
fwd/rpsE-RT-rev and rpsJ-RT-fwd/rpsJ-RT-rev,r e s p e c -
tively. The expression ratios were calculated as fold
changes as described [38]. RT-PCR experiments were
performed in duplicate.
Additional material
Additional file 1: Supplementary Table S1. This Table lists the
sequences of the oligonucleotide primers used in the experiments.
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